Characterization of Malignant Mesenchymal Cell Line (UISO-RS-3) Derived from a Human Rhabdomyosarcoma and Inhibition by Pharmacologic Doses of Estrogen

Overview

Journal In Vitro Cell Dev Biol

Specialties Anatomy & Histology
Cell Biology

Date 1990 Oct 1

PMID 2243060

Citations 1

Authors

W E Madsen

M J Walker

E A Shaughnessy

J M Brown

T K Das Gupta

Affiliations

Soon will be listed here.

Abstract

A new tumor cell line has been established from a malignant pleural effusion in a 28-yr-old female patient with a primary alveolar rhabdomyosarcoma of the left buttock. The in vitro and in vivo growth characteristics, morphologic features, abnormal karyotype, and immunohistochemical staining pattern indicate that this cell line is comprised of primitive malignant mesenchymal cells derived from a human rhabdomyosarcoma. Receptor studies done on tumors grown in male athymic mice revealed a single class of high affinity saturable cytoplasmic estrogen receptor (Bmax 2.6 fm/mg cytosol protein, Kd 0.34 nM). Likewise, sucrose density gradient analysis demonstrated specific low-capacity, high-affinity estradiol binding predominately in the 8S region. Cell growth in monolayer culture and on soft agar in the presence of estradiol was inhibited by pharmacologic concentrations of estradiol in a dose-responsive manner compared with control. We describe a newly characterized malignant mesenchymal cell line derived from an alveolar rhabdomyosarcoma that is inhibited by pharmacologic doses of estradiol in vitro. These findings suggest further investigation into the mechanism(s) of this estrogen-induced inhibition in rhabdomyosarcomas.

Citing Articles

Human rhabdomyosarcoma cell lines for rhabdomyosarcoma research: utility and pitfalls.

Hinson A, Jones R, Crose L, Belyea B, Barr F, Linardic C Front Oncol. 2013; 3:183.

PMID: 23882450 PMC: 3713458. DOI: 10.3389/fonc.2013.00183.

References

Miettinen M, Lehto V, Badley R, Virtanen I . Alveolar rhabdomyosarcoma. Demonstration of the muscle type of intermediate filament protein, desmin, as a diagnostic aid. Am J Pathol. 1982; 108(2):246-51. PMC: 1916077. View

Walker M, Chaudhuri P, Beattie C, Das Gupta T . Steroid receptors in malignant skeletal tumors. Cancer. 1980; 45(12):3004-7. DOI: 10.1002/1097-0142(19800615)45:12<3004::aid-cncr2820451221>3.0.co;2-p. View

Walker M, Lim C, Das Gupta T, Beattie C . Effects of glucocorticoids on the growth of human fibrosarcoma cell line HT-1080. Cancer Res. 1986; 46(10):4927-32. View

Chen T . In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain. Exp Cell Res. 1977; 104(2):255-62. DOI: 10.1016/0014-4827(77)90089-1. View

Franke W, Schmid E, Osborn M, Weber K . Different intermediate-sized filaments distinguished by immunofluorescence microscopy. Proc Natl Acad Sci U S A. 1978; 75(10):5034-8. PMC: 336257. DOI: 10.1073/pnas.75.10.5034. View

Kern D, Bertelsen C, Mann B, Campbell M, Morton D, Cochran A . Clinical application of the clonogenic assay. Ann Clin Lab Sci. 1983; 13(1):10-5. View

Martin R, Ames B . A method for determining the sedimentation behavior of enzymes: application to protein mixtures. J Biol Chem. 1961; 236:1372-9. View

Rasheed S, Nelson-Rees W, Toth E, ARNSTEIN P, Gardner M . Characterization of a newly derived human sarcoma cell line (HT-1080). Cancer. 1974; 33(4):1027-33. DOI: 10.1002/1097-0142(197404)33:4<1027::aid-cncr2820330419>3.0.co;2-z. View

Stuckly K, Kiddle R, Leversha M, Ellis W, Ekert H . Establishment and partial characterisation of a human fibrosarcoma cell line MR-83. Aust J Exp Biol Med Sci. 1985; 63 ( Pt 4):431-8. DOI: 10.1038/icb.1985.48. View

10.

ENZINGER F, Shiraki M . Alveolar rhabdomyosarcoma. An analysis of 110 cases. Cancer. 1969; 24(1):18-31. DOI: 10.1002/1097-0142(196907)24:1<18::aid-cncr2820240103>3.0.co;2-5. View

11.

Bonne C, Raynaud J . Assay of androgen binding sites by exchange with methyltrienolone (R 1881). Steroids. 1976; 27(4):497-507. DOI: 10.1016/0039-128x(76)90084-2. View

12.

Gard D, Lazarides E . The synthesis and distribution of desmin and vimentin during myogenesis in vitro. Cell. 1980; 19(1):263-75. DOI: 10.1016/0092-8674(80)90408-0. View

13.

Cesarone C, Bolognesi C, Santi L . Improved microfluorometric DNA determination in biological material using 33258 Hoechst. Anal Biochem. 1979; 100(1):188-97. DOI: 10.1016/0003-2697(79)90131-3. View

14.

Chaudhuri P, Walker M, Beattie C, Das Gupta T . Presence of steroid receptors in human soft tissue sarcomas of diverse histological origin. Cancer Res. 1980; 40(3):861-5. View

15.

Altmannsberger M, Weber K, Droste R, Osborn M . Desmin is a specific marker for rhabdomyosarcomas of human and rat origin. Am J Pathol. 1985; 118(1):85-95. PMC: 1887849. View

16.

Churg A, Ringus J . Ultrastructural observations on the histogenesis of alveolar rhabdomyosarcoma. Cancer. 1978; 41(4):1355-61. DOI: 10.1002/1097-0142(197804)41:4<1355::aid-cncr2820410420>3.0.co;2-a. View

17.

Jackson B, Grund C, Schmid E, Burki K, Franke W, Illmensee K . Formation of cytoskeletal elements during mouse embryogenesis. Intermediate filaments of the cytokeratin type and desmosomes in preimplantation embryos. Differentiation. 1980; 17(3):161-79. DOI: 10.1111/j.1432-0436.1980.tb01093.x. View

18.

Osborn M, Altmannsberger M, Debus E, Weber K . Differentiation of the major human tumor groups using conventional and monoclonal antibodies specific for individual intermediate filament proteins. Ann N Y Acad Sci. 1985; 455:649-68. DOI: 10.1111/j.1749-6632.1985.tb50442.x. View

19.

Chaudhuri P, Walker M, Beattie C, Das Gupta T . Distribution of steroid hormone receptors in human soft tissue sarcomas. Surgery. 1981; 90(2):149-53. View

20.

Katzenellenbogen B, Tsai T, Tatee T, Katzenellenbogen J . Estrogen and antiestrogen action: studies in reproductive target tissues and tumors. Adv Exp Med Biol. 1979; 117:111-32. DOI: 10.1007/978-1-4757-6589-2_6. View